These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Recurrent follicular carcinoma-oxyphilic cell type (Hürthle cell carcinoma) of the thyroid, imaging with iodine-131 and technetium-99m tetrofosmin before and after radiotherapy. Bomanji JB; Gacinovic S; Gaze MN; Costa DC; Ell PJ Br J Radiol; 1998 Jan; 71(841):87-9. PubMed ID: 9534706 [TBL] [Abstract][Full Text] [Related]
4. Comparison of technetium-99m-MIBI and thallium-201-chloride uptake in primary thyroid lymphoma. Scott AM; Kostakoglu L; O'Brien JP; Straus DJ; Abdel-Dayem HM; Larson SM J Nucl Med; 1992 Jul; 33(7):1396-8. PubMed ID: 1613584 [TBL] [Abstract][Full Text] [Related]
5. Technetium 99m pentavalent dimercaptosuccinic acid and thallium 201 in detecting recurrent medullary carcinoma of the thyroid. Bigsby RJ; Lepp EK; Litwin DE; Wilkinson AA; Matte GG Can J Surg; 1992 Aug; 35(4):388-92. PubMed ID: 1323381 [TBL] [Abstract][Full Text] [Related]
6. Tc-99m-tetrofosmin scintigraphy: an alternative scintigraphic method for following up differentiated thyroid carcinoma--preliminary results. Gallowitsch HJ; Kresnik E; Mikosch P; Pipam W; Gomez I; Lind P Nuklearmedizin; 1996 Dec; 35(6):230-5. PubMed ID: 8976503 [TBL] [Abstract][Full Text] [Related]
8. Comparative radionuclide imaging of metastatic insular carcinoma of the thyroid: value of technetium-99m-(V)DMSA. Yen TC; King KL; Yang AH; Liu RS; Yeh SH J Nucl Med; 1996 Jan; 37(1):78-80. PubMed ID: 8544007 [TBL] [Abstract][Full Text] [Related]
9. F-18 FDG uptake by recurrent Hürthle cell carcinoma of the thyroid using high-energy planar scintigraphy. Blount CL; Dworkin HJ Clin Nucl Med; 1996 Nov; 21(11):831-3. PubMed ID: 8922841 [TBL] [Abstract][Full Text] [Related]
10. The role of technetium-99m sestamibi whole-body scans in diagnosing metastatic Hürthle cell carcinoma of the thyroid gland after total thyroidectomy: a comparison with iodine-131 and thallium-201 whole-body scans. Yen TC; Lin HD; Lee CH; Chang SL; Yeh SH Eur J Nucl Med; 1994 Sep; 21(9):980-3. PubMed ID: 7995293 [TBL] [Abstract][Full Text] [Related]
11. Technetium-99m tetrofosmin uptake in insular thyroid carcinoma. A comparison with iodine-131. Degirmenci B; Aydin A; Comlekci A; Ozdogan O; Bekis R Clin Nucl Med; 2003 May; 28(5):385-8. PubMed ID: 12702934 [TBL] [Abstract][Full Text] [Related]
12. Recurrent medullary carcinoma of the thyroid demonstrated by thallium-201 scintigraphy. Arnstein NB; Juni JE; Sisson JC; Lloyd RV; Thompson NW J Nucl Med; 1986 Oct; 27(10):1564-8. PubMed ID: 3760981 [TBL] [Abstract][Full Text] [Related]
18. Tc-99m sestamibi and In-111 pentetreotide uptake in metastatic papillary thyroid carcinoma. Lee J; Cutrone JA; Marcus CS Clin Nucl Med; 1995 Oct; 20(10):867-8. PubMed ID: 8616988 [TBL] [Abstract][Full Text] [Related]
19. Radionuclide imaging in medullary thyroid carcinoma: evaluation of two new radiopharmaceuticals. Clarke SE; Lazarus CR; Maisey MN Henry Ford Hosp Med J; 1987; 35(2-3):124-6. PubMed ID: 2826368 [No Abstract] [Full Text] [Related]
20. 201ti scintigraphy in postoperative detection of thyroid cancer: a comparative study with 131i. Tonami N; Hisada K Radiology; 1980 Aug; 136(2):461-4. PubMed ID: 7403524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]